Similar articles

• Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes.

  Zupanc ML, Moraes CT, Shanske S, Langman CB, Ciafaloni E, DiMauro S. Zupanc ML, et al. Ann Neurol. 1991 Jun;29(6):680-3. doi: 10.1002/ana.410290619. Ann Neurol. 1991. PMID: 1892371
• Neurological disease and mitochondrial genes.

  Harding AE. Harding AE. Trends Neurosci. 1991 Apr;14(4):132-8. doi: 10.1016/0166-2236(91)90081-5. Trends Neurosci. 1991. PMID: 1710848 Review.
• [Mitochondrial abnormalities and diseases].

  Goto Y, Sugita H. Goto Y, et al. Nihon Naika Gakkai Zasshi. 1991 May 10;80(5):775-80. Nihon Naika Gakkai Zasshi. 1991. PMID: 1651974 Japanese. No abstract available.
• Localization of mitochondrial DNA in normal and pathological muscle using immunological probes: a new approach to the study of mitochondrial myopathies.

  Andreetta F, Tritschler HJ, Schon EA, DiMauro S, Bonilla E. Andreetta F, et al. J Neurol Sci. 1991 Sep;105(1):88-92. doi: 10.1016/0022-510x(91)90123-o. J Neurol Sci. 1991. PMID: 1665507
• Neuro-ophthalmologic manifestations of mitochondrial DNA disorders: chronic progressive external ophthalmoplegia, Kearns-Sayre syndrome, and Leber's hereditary optic neuropathy.

  Kosmorsky G, Johns DR. Kosmorsky G, et al. Neurol Clin. 1991 Feb;9(1):147-61. Neurol Clin. 1991. PMID: 2011107 Review. No abstract available.